| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.15T | 1.06T | 1.07T | 951.88B | 830.24B |
| Gross Profit | 186.17B | 185.77B | 181.97B | 135.71B | 116.89B |
| EBITDA | 136.55B | 121.78B | 124.13B | 86.69B | 74.45B |
| Net Income | 62.01B | 36.33B | 51.45B | 16.00B | 23.35B |
Balance Sheet | |||||
| Total Assets | 992.91B | 913.04B | 933.35B | 865.30B | 859.30B |
| Cash, Cash Equivalents and Short-Term Investments | 131.81B | 118.77B | 146.00B | 105.27B | 109.14B |
| Total Debt | 123.34B | 120.03B | 150.02B | 174.93B | 186.30B |
| Total Liabilities | 377.74B | 324.63B | 366.61B | 378.93B | 396.50B |
| Stockholders Equity | 568.56B | 542.63B | 522.34B | 448.41B | 428.81B |
Cash Flow | |||||
| Free Cash Flow | 74.24B | 33.63B | 81.66B | 7.84B | -24.07B |
| Operating Cash Flow | 131.69B | 92.01B | 128.37B | 53.97B | 27.66B |
| Investing Cash Flow | -49.65B | -71.82B | -40.69B | -31.59B | -59.43B |
| Financing Cash Flow | -70.89B | -50.68B | -53.07B | -28.93B | 2.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥245.08B | 8.29 | ― | 3.36% | 4.89% | 52.78% | |
79 Outperform | ¥422.78B | 11.25 | ― | 1.60% | -2.91% | 103.94% | |
78 Outperform | ¥295.11B | 8.56 | 6.37% | 2.88% | 4.27% | 24.02% | |
76 Outperform | ¥711.56B | 14.05 | 7.20% | 2.41% | 2.31% | 26.37% | |
74 Outperform | ¥531.09B | 6.74 | 8.58% | 2.62% | 8.21% | 72.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥394.26B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% |